- Markets
- Healthcare
- PARNAXLAB
PARNAXLAB
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Parnax Lab CEO Prakash M. Shah Resigns
July 5 (Reuters) - Parnax Lab Ltd PALA.BO:
PRAKASH M. SHAH RESIGNS AS CEO
BAIJU M. SHAH RESIGNS AS MD, CFO
Source text for Eikon: ID:nBSE8FHqMx
Further company coverage: PALA.BO
(([email protected];))
July 5 (Reuters) - Parnax Lab Ltd PALA.BO:
PRAKASH M. SHAH RESIGNS AS CEO
BAIJU M. SHAH RESIGNS AS MD, CFO
Source text for Eikon: ID:nBSE8FHqMx
Further company coverage: PALA.BO
(([email protected];))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Parnax Lab do?
Parnax Lab Limited manufactures and exports pharmaceutical formulations. They have manufacturing facilities in sectors such as pharmaceuticals, cosmetics, herbal medicine, and nutraceuticals. The company operates in Silvassa and Baddi, Himachal Pradesh.
Who are the competitors of Parnax Lab?
Parnax Lab major competitors are Source Natural Foods, Murae Organisor, Samrat Pharmachem, Mangalam Drugs&Org., Smruthi Organics, Bharat Immunological, Sotac Pharmaceutical. Market Cap of Parnax Lab is ₹119 Crs. While the median market cap of its peers are ₹130 Crs.
Is Parnax Lab financially stable compared to its competitors?
Parnax Lab seems to be less financially stable compared to its competitors. Altman Z score of Parnax Lab is 2.27 and is ranked 5 out of its 8 competitors.
Does Parnax Lab pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Parnax Lab latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Parnax Lab allocated its funds?
Companies resources are allocated to majorly unproductive assets like Capital Work in Progress
How strong is Parnax Lab balance sheet?
Balance sheet of Parnax Lab is moderately strong, But short term working capital might become an issue for this company.
Is the profitablity of Parnax Lab improving?
Yes, profit is increasing. The profit of Parnax Lab is ₹10.86 Crs for TTM, ₹9.61 Crs for Mar 2024 and ₹8.62 Crs for Mar 2023.
Is the debt of Parnax Lab increasing or decreasing?
The debt of Parnax Lab is decreasing. Latest debt of Parnax Lab is ₹64.32 Crs as of Sep-24. This is less than Mar-24 when it was ₹67.33 Crs.
Is Parnax Lab stock expensive?
Parnax Lab is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Parnax Lab is 10.99, while 3 year average PE is 21.91. Also latest EV/EBITDA of Parnax Lab is 7.07 while 3yr average is 6.92.
Has the share price of Parnax Lab grown faster than its competition?
Parnax Lab has given better returns compared to its competitors. Parnax Lab has grown at ~21.35% over the last 2yrs while peers have grown at a median rate of -8.83%
Is the promoter bullish about Parnax Lab?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Parnax Lab is 72.3% and last quarter promoter holding is 72.3%.
Are mutual funds buying/selling Parnax Lab?
There is Insufficient data to gauge this.